X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (120) 120
index medicus (62) 62
monoclonal-antibody alk1 (55) 55
female (46) 46
male (44) 44
oncology (43) 43
monoclonal antibodies (42) 42
non-hodgkins-lymphoma (41) 41
animals (36) 36
hematology (35) 35
receptor protein-tyrosine kinases (35) 35
adult (34) 34
pathology (34) 34
cancer (32) 32
immunohistochemistry (31) 31
middle aged (31) 31
ki-1 lymphoma (26) 26
aged (25) 25
monoclonal-antibody (25) 25
adolescent (24) 24
protein-tyrosine kinases - genetics (24) 24
angiogenesis (23) 23
immunophenotyping (22) 22
child (20) 20
lymphoma, large-cell, anaplastic - pathology (20) 20
polymerase chain-reaction (20) 20
translocation, genetic (20) 20
expression (19) 19
anaplastic large cell lymphoma (18) 18
disease (18) 18
tumors (18) 18
care and treatment (17) 17
t (17) 17
lymphoma, large b-cell, diffuse - pathology (16) 16
prognosis (16) 16
anaplastic lymphoma kinase (15) 15
chromosomes, human, pair 2 (15) 15
endoglin (15) 15
analysis (14) 14
chemotherapy (14) 14
lymphoma, large-cell, anaplastic - genetics (14) 14
lymphomas (14) 14
research (14) 14
signal transduction (14) 14
child, preschool (13) 13
pharmacology & pharmacy (13) 13
t-cell (13) 13
therapy (13) 13
antineoplastic agents - therapeutic use (12) 12
gene (12) 12
lymphoma, large b-cell, diffuse - genetics (12) 12
protein (12) 12
proteins (12) 12
receptor tyrosine kinase (12) 12
antibodies, monoclonal - therapeutic use (11) 11
cell biology (11) 11
genetic aspects (11) 11
health aspects (11) 11
hemic and lymphatic diseases (11) 11
protein-tyrosine kinases - analysis (11) 11
protein-tyrosine kinases - metabolism (11) 11
tgf-beta (11) 11
translocation (11) 11
chromosomes, human, pair 5 (10) 10
hereditary hemorrhagic telangiectasia (10) 10
in situ hybridization, fluorescence (10) 10
monoclonal-antibodies (10) 10
neoplasms - drug therapy (10) 10
aged, 80 and over (9) 9
alk (9) 9
antibodies (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
infant (9) 9
kinase alk (9) 9
lymphoma (9) 9
models, biological (9) 9
monoclonal antibody (9) 9
oncogene proteins, fusion - genetics (9) 9
pharmacokinetics (9) 9
phosphorylation (9) 9
receptor (9) 9
treatment outcome (9) 9
article (8) 8
endothelial growth-factor (8) 8
epstein-barr-virus (8) 8
growth (8) 8
immunoglobulins (8) 8
lymphoma, large b-cell, diffuse - classification (8) 8
medicine, research & experimental (8) 8
metastasis (8) 8
mice (8) 8
molecular sequence data (8) 8
non-hodgkins-lymphomas (8) 8
npm-alk (8) 8
nuclear proteins - genetics (8) 8
protein-tyrosine kinases - biosynthesis (8) 8
vascular endothelial growth factor (8) 8
viral antibodies (8) 8
alk1 (7) 7
antibodies, monoclonal - pharmacokinetics (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer research, ISSN 0008-5472, 06/2015, Volume 75, Issue 12, pp. 2445 - 2456
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 51, pp. 84314 - 84325
Journal Article
Cancer Research, ISSN 0008-5472, 02/2011, Volume 71, Issue 4, pp. 1362 - 1373
Journal Article
Investigational New Drugs, ISSN 0167-6997, 06/2014, Volume 32, Issue 3, p. 555
  Despite a compelling preclinical rationale for the use of anti-angiogenic drugs in urothelial cancer (UC), short-living responses have been observed in... 
Complications and side effects | Monoclonal antibodies | Dosage and administration | Genetic aspects | Research | Drug therapy | Urinary tract cancer | Statistical analysis | Research & development--R&D | Clinical trials | Patients | Cancer therapies | Drug dosages | Pharmaceuticals
Journal Article
Cardiovascular Pathology, ISSN 1054-8807, 11/2017, Volume 31, pp. 26 - 33
Activin receptor-like kinase 1 (ALK1) mediates signaling via the transforming growth factor beta-1 (TGFβ1), a pro-fibrogenic cytokine. No studies have defined... 
Heart failure | Cardiac fibrosis | Transforming growth factor beta | Activin receptor like kinase 1 | CARDIAC & CARDIOVASCULAR SYSTEMS | ADVANCED SOLID TUMORS | ANGIOGENESIS | PF-03446962 | HUMAN MONOCLONAL-ANTIBODY | PATHOLOGY | CANCER | ALK1 | PHASE-I | TYPE-2
Journal Article
Cancer Research, ISSN 0008-5472, 06/1999, Volume 59, Issue 12, pp. 2776 - 2780
Journal Article
Journal Article
Journal Article
Journal Article